Skip to content
West Midlands Cancer Alliance
  • Home
  • About us
    • About the West Midlands Cancer Alliance
      • Our Partners
    • Who We Are
      • Governance
      • Our Board
      • Board Briefings
      • Patient Engagement & Involvement
    • Meet the Team
    • News
    • Newsletters
    • Contact
  • Our work
    • Early Diagnosis
      • Screening
        • Lung Cancer Screening
        • Bowel Screening
        • Cervical Screening
        • Breast Screening
    • Treatment and Care
      • Living With and Beyond Cancer
      • Treatment
    • Health Inequalities and Community Engagement
    • Innovation
  • Patients' area
    • Patient and Public Resources
    • How to Get Involved
    • Patient Advocates
    • External Patient Groups
    • Common side effects of non-surgical cancer treatments
    • Patient Surveys
      • Quality of Life Survey
      • National Cancer Patient Experience Survey
      • Under 16 Cancer Patient Experience Survey
    • Patient Information
    • Video Library
      • Cancer Screening Videos
      • Cancer Treatment Videos
      • Breast Cancer Videos
      • Bowel Cancer Videos
      • Prostate Cancer Videos
      • Cervical Cancer Videos
      • Lung Cancer Videos
  • Professionals' area
    • Primary Care Resources, Learning and Development
      • Screening and Early Diagnosis Resources
      • Tumour Site Specific Resources
      • Urgent Suspected Cancer Referral Forms
      • Prostate Toolkit
        • Why This MattersWhy This Matters
        • Take Action in Your PracticeTake Action in Your Practice
        • Quick Clinical GuideQuick Clinical Guide
        • Communication and System ToolsCommunication and System Tools
        • Awareness CampaignsAwareness Campaigns
        • Patient StoriesPatient Stories
        • Primary Care Best PracticePrimary Care Best Practice
        • Ready-to-Use ResourcesReady-to-Use Resources
        • Education and TrainingEducation and Training
        • Key ContactsKey Contacts
    • Clinical Resources
    • Health Inequalities Resources
    • Expert Advisory Groups
      • Acute Oncology, Metastatic Spinal Cord Compression and Cancer of Unknown Primary
      • Brain and Central Nervous System
      • Breast
      • Children's
      • Colorectal
      • Gynaecology
      • Haematology
      • Head and Neck
      • Hepatobiliary (HPB)
      • Lung
      • Neuroendocrine (NET)
      • Non-Specific Symptoms (NSS)
      • Primary Care
      • Psychosocial
      • Radiotherapy
      • Systemic Anti-Cancer Therapy (SACT)
      • Sarcoma
      • Skin
      • Teenage and Young Adults (TYA)
      • Upper Gastrointestinal
      • Urology
    • Operational Delivery Network
      • Pathology
    • Performance Standards
      • The Cancer Dashboard
      • Faster Diagnosis Standard
      • Best Practice Timed Pathway
    • Midlands Cancer Alliances Life Sciences Hub
  • Cancer Academy
    • WMCA Cancer Careers and Education programme
    • ePortfolio
    • Upcoming training
    • Additional learning resources
Back to top Go to content
West Midlands Cancer Alliance
  • Home
  • About us
    • About the West Midlands Cancer Alliance
    • Who We Are
    • Meet the Team
    • News
    • Newsletters
    • Contact
  • Our work
    • Early Diagnosis
    • Treatment and Care
    • Health Inequalities and Community Engagement
    • Innovation
  • Patients' area
    • Patient and Public Resources
    • How to Get Involved
    • Patient Advocates
    • External Patient Groups
    • Common side effects of non-surgical cancer treatments
    • Patient Surveys
    • Patient Information
    • Video Library
  • Professionals' area
    • Primary Care Resources, Learning and Development
    • Clinical Resources
    • Health Inequalities Resources
    • Expert Advisory Groups
    • Operational Delivery Network
    • Performance Standards
    • Midlands Cancer Alliances Life Sciences Hub
  • Cancer Academy
    • WMCA Cancer Careers and Education programme
    • ePortfolio
    • Upcoming training
    • Additional learning resources

Expert Advisory Groups

Neuroendocrine (NET)

  • Primary Care Resources, Learning and Development
    • Screening and Early Diagnosis Resources
    • Tumour Site Specific Resources
    • Urgent Suspected Cancer Referral Forms
    • Prostate Toolkit
      • Why This MattersWhy This Matters
      • Take Action in Your PracticeTake Action in Your Practice
      • Quick Clinical GuideQuick Clinical Guide
      • Communication and System ToolsCommunication and System Tools
      • Awareness CampaignsAwareness Campaigns
      • Patient StoriesPatient Stories
      • Primary Care Best PracticePrimary Care Best Practice
      • Ready-to-Use ResourcesReady-to-Use Resources
      • Education and TrainingEducation and Training
      • Key ContactsKey Contacts
  • Clinical Resources
  • Health Inequalities Resources
  • Expert Advisory Groups
    • Acute Oncology, Metastatic Spinal Cord Compression and Cancer of Unknown Primary
    • Brain and Central Nervous System
    • Breast
    • Children's
    • Colorectal
    • Gynaecology
    • Haematology
    • Head and Neck
    • Hepatobiliary (HPB)
    • Lung
    • Neuroendocrine (NET)
    • Non-Specific Symptoms (NSS)
    • Primary Care
    • Psychosocial
    • Radiotherapy
    • Systemic Anti-Cancer Therapy (SACT)
    • Sarcoma
    • Skin
    • Teenage and Young Adults (TYA)
    • Upper Gastrointestinal
    • Urology
  • Operational Delivery Network
    • Pathology
  • Performance Standards
    • The Cancer Dashboard
    • Faster Diagnosis Standard
    • Best Practice Timed Pathway
  • Midlands Cancer Alliances Life Sciences Hub

Neuroendocrine (NET)

Neuroendocrine Tumours (NETs) are rare.  NETs develop in different parts of the body and behave in different ways.  Most NETs develop slowly over some years. They may not cause symptoms in the early stages so it is not unusual for people to find that a NET has already spread to another part of the body when they are diagnosed.

More recently doctors have been calling them neuroendocrine neoplasms (NENs). This is an umbrella term for this group of disorders. Then depending on how slow or fast growing the cells are they are called either neuroendocrine tumours (NETs) or neuroendocrine carcinomas (NECs).

Around 5 out of every 10 NETs start in the gastrointestinal (GI) system.  Around 2 out of every 10 NETs start in the lung.  In some cases, doctors do not know where the original NET started.  This is called cancer of unknown primary (CUP).

Over 4,000 people are diagnosed with a NET each year in the UK. They are getting more common across the world. This might be because there are better tests to diagnose them.

The aim of the NET EAG group is to formally develop pathways across the Midlands that are equitable and consistent. The pathways are to be aligned to national guidance and best practice.  There are 2 centres of excellence; University Hospitals Birmingham (UHB) and University of Coventry & Warwickshire (UHCW) who offer NET advice to local hospitals in the region.

Chair: Mr Samuel Ford, Consultant Surgeon, University Hospitals Birmingham

Deputy Chair: Ms. Stacey Smith, Neuroendocrine Tumour CNS, University Hospitals Birmingham

Guidelines:

Neuroendocrine Cancer UK: An Ideal Patient Care Pathway
Popular
Neuroendocrine Tumour: Small Bowel Pathway January 2023
Popular

Documents: 

ENETs SOP on Centres of Excellence
Popular

Neuroendocrine Cancer UK Video: High Grade Neuroendocrine Carcinoma Explained

Useful links:

Neuroendocrine Cancer UK: Conferences & Events

INCA: Find a Clinical Trial

INCA: NET Cancer Advocacy and Policy Toolkit

YouTube: INCA Genetic NETs Video

ESMO Clinical Practice Guidelines: endocrine & neuroendocrine cancers

Neuroendocrine tumours and carcinoid syndrome - NHS

What are neuroendocrine tumours (NETs)? | Cancer Research UK

Neuroendocrine tumours (NETs) - Macmillan

Pancreatic NETs - Cancer Research UK

Lung NETs - Cancer Research UK

Stomach NETs - Cancer Research UK

Small Bowel NETs - Cancer Research UK

Large Bowel/Rectal NETs - Cancer Research UK

Video: treating neuroendocrine tumours - British Society of Gastroenterology (BSG)

Neuroendocrine Cancer UK

UK and Ireland Neuroendocrine Tumour Society

European Neuroendocrine Tumor Society (ENETS)

International Conference on Neuroendocrine Tumors and Preventine

British Society for Neuroendocrinology

Journal of Endocrinology

Targeted radionuclide therapy for NETs | Macmillan Cancer Support

Somatostatin analogues for neuroendocrine tumours (NETs) | Macmillan Cancer Support

British Nuclear Medicine Society

Radionuclide Supply - British Nuclear Medicine Society

Contact Us

West Midlands Cancer Alliance
23 Stephenson Street
Birmingham
B2 4BJ

rwh-tr.wmcanceralliance@nhs.net

@NHS_WMCA

West Midlands Cancer Alliance Logo White

Icon: This website is powered by 100% renewable energy
Icon: Click here to find out more

Website by Volute

Accessibility | Privacy | Cookies | Terms & Conditions